The Crucial Role of the Pathologist in the Multidisciplinary Care Team for NSCLC
A CME-certified Program



Registration Statement


By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements below.


Registration

  VenueCityStateDate
View Agenda  Red Lion HotelHarrisburgPA Friday
Apr 8, 2016 5:30 PM
View Agenda  The Ballantyne HotelCharlotteNC Friday
Apr 15, 2016 4:30 PM
View Agenda  University of Maryland SMC Campus Center BaltimoreMD Saturday
Jun 4, 2016 1:00 PM
View Agenda  Manor Vail Lodge VailCO Saturday
Jul 16, 2016 12:15 PM
View Agenda  The Marten House Lilly Conference Center IndianapolisIN Saturday
Aug 13, 2016 11:30 AM
View Agenda  Hyatt Regency San Francisco San FranciscoCA Thursday
Dec 1, 2016 12:30 PM


Presentation Slides


Click here to view the presentation slides and transcript from this CME-certified series held at select College of American Pathologists (CAP) state chapter meetings. (coming soon)

Program Description

Novel targeted therapies have transformed the outcomes of patients with NSCLC, and pathologists play a crucial role in assessing if patients are eligible for these targeted therapies. Community pathologists must be kept up to date with recommendations for pathologic testing to properly individualize treatments for NSCLC. There is also an increasing need to improve communication between the members of the multidisciplinary cancer care team to ensure the accurate diagnosis and management of NSCLC.

The Crucial Role of the Pathologist in the Multidisciplinary Care Team for NSCLC will provide community clinicians with the latest recommendations for pathological testing to guide personalized treatment selections in NSCLC, keep clinicians up to date with clinical practice guidelines, and provide them with the tools needed to engage their patients in treatment decisions.

Agenda


I. Welcome and Introduction
II. Histologic and Molecular Testing
III. Clinical Case Discussions
-       Lung adenocarcinoma with EGFR mutation
-       Squamous cell lung carcinoma
-       K-Ras-positive lung adenocarcinoma
IV. Questions and Discussion

Target Audience

This program is intended for community-based pathologists, oncologists, oncology nurses, pulmonologists, and other healthcare professionals involved in the care of patients with NSCLC.


Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate the ability to:
  • Assess evidence-based biopsy and molecular testing methods for use in clinical practice
  • Evaluate personalization of treatments of NSCLC based on molecular and immunologic biomarkers
  • Understand the need for effective communication within the multidisciplinary team and with patients to formulate optimal treatment plans

Steering Committee


Alain C. Borczuk, MD
Vice Chairman for Anatomic Pathology
Director of Anatomic Pathology
Chief of Thoracic Pathology
Weill Cornell Medicine
New York, NY

Read Biography 

Balazs Halmos, MD
Director, Thoracic Oncology and Clinical Cancer Genomics
Montefiore Medical Center/Albert Einstein College of Medicine
New York, NY

 Read Biography

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe Oncology. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

For questions regarding CME credit or the evaluation, please email contact@potomacme.org

Disclosure Information

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.


FDA Disclosure

The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Method of Participation

To complete the activity and receive credit, the participant must attend the program and complete the evaluation form. A CME certificate will be provided after submission of a completed evaluation form.

There is no fee associated with this program.

SPECIAL SERVICES

Event staff will be glad to assist you with any specials needs.  Please email specialservices@rockpointe-pcme.com at least 5 days prior to the program.


Jointly provided by Potomac Center for Medical Education and Rockpointe Oncology

     
     


     

Supported by independent educational grants from Genentech, Lilly, and Merck & Co., Inc.

Registration Statement


By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements above.

Registration is for planning purposes only. Seating is limited and will be provided on a first-come, first-served basis.



Registration

  VenueCityStateDate
View Agenda  Red Lion HotelHarrisburgPA Friday
Apr 8, 2016 5:30 PM
View Agenda  The Ballantyne HotelCharlotteNC Friday
Apr 15, 2016 4:30 PM
View Agenda  University of Maryland SMC Campus Center BaltimoreMD Saturday
Jun 4, 2016 1:00 PM
View Agenda  Manor Vail Lodge VailCO Saturday
Jul 16, 2016 12:15 PM
View Agenda  The Marten House Lilly Conference Center IndianapolisIN Saturday
Aug 13, 2016 11:30 AM
View Agenda  Hyatt Regency San Francisco San FranciscoCA Thursday
Dec 1, 2016 12:30 PM